G
GILD
Gilead Sciences Inc
151.40
0.28+0.19%After Hours: 151.25 -0.15 -0.10%19:42 02/20 EST
OPEN/PREV CLOSE150.58/151.12
TODAY RANGE150.09-153.26
VOL6.99M
MARKET CAP187.84B
52 WEEK RANGE91.47-157.29
AVG VOL (3M)7.29M
% TURNOVER0.56%
TURNOVER--
P/E (TTM)22.33
% RANGE2.09%
EPS(TTM)6.78
P/E(FORWARD)21.44
P/B8.31
BVPS18.23
DIVIDEND3.280
P/S6.38
BETA--
DIV YIELD2.17%
FREE FLOAT MKT CAP187.63B
SHARES OUTSTANDING1.24B
NEXT EARNINGS04/22-04/27
FREE FLOAT1.24B
LOT SIZE1
EX-DATE03/13/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·19h ago
Pharmaceutical tariffs still in play despite Supreme Court ruling
Seeking Alpha·20h ago
Time To Take Profits On Gilead Sciences (Rating Downgrade)
Seeking Alpha·1d ago
Tracking Renaissance Technologies (RenTec) 13F Portfolio - Q4 2025 Update
Dow Jones·1d ago
Gilead Sciences Initiated at Equal-Weight by Barclays
TipRanks·1d ago
Gilead initiated with an Equal Weight at Barclays
Seeking Alpha·1d ago
China drug licensing deals surge nearly 10-fold in value since 2021
Benzinga·1d ago
Peering Into Gilead Sciences Inc's Recent Short Interest
Reuters·2d ago
Zimbabwe rolls out new HIV prevention drug lenacapavir
Reuters·2d ago
U.S. RESEARCH ROUNDUP-EBay, Huntsman, Palo Alto
Reuters·2d ago
Gilead CFO Andrew D. Dickinson Disposes of Common Shares
Seeking Alpha·2d ago
NIH director reportedly being tapped as acting CDC director
Same Industry
Name/Symbol
Change%
Price